Open Journal Systems

Open innovation to bolster research and development for neglected and emerging infectious diseases

Jennifer Dent, Katy M Graef, Paddy Shivanand

Abstract

Infections remain a significant cause of disease, disability, and death in developing countries. Unfortunately, many of these infections, including centuries-old neglected diseases such as malaria and newly emerging and re-emerging diseases such as Ebola virus disease (EVD), have limited products available to prevent, diagnose, and treat them. One barrier that hinders the development of these products is neglected and emerging disease experts’ limited access to the biopharmaceutical industry’s small molecules, technologies, and know-how. Conversely, the biopharmaceutical industry’s lack of attention to and expertise in these diseases impedes the development of much-needed products. Organisations are addressing these challenges by developing platforms through which disease experts can access industry’s knowledge and assets. Strategic partnerships are applying a synergistic approach to leverage respective strengths of academia and industry. The following article describes two open innovation platforms, the Pool for Open Innovation against Neglected Tropical Diseases (POINT) and WIPO Re:Search, and two strategic, cross-sector collaborative efforts to develop therapeutics for EVD.


Keywords

neglected tropical diseases; Ebola virus disease; global health; POINT; WIPO Re:Search

Full Text:

PDF

References

Savioli L and Daumerie D, 2010, First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases, World Health Organization, viewed May 18, 2015,

Norris J, Adelman C, Spantchak Y, et al. 2012, Social and economic impact review on neglected tropical diseases, Hudson Institute and Global Network for Neglected Tropical Diseases, viewed May 18, 2015,

Shepard D S, Coudeville L, Halasa Y A, et al. 2011, Economic impact of dengue illness in the Americas. American Journal of Tropical Medicine and Hygiene, vol.84(2): 200–207. http://dx.doi.org/10.4269/ajtmh.2011.10-0503.

Engels D and Daumerie D, 2015, Third WHO report on neglected tropical diseases: investing to overcome the global impact of neglected tropical diseases, World Health Organization, viewed May 18, 2015,

Global Health Observatory Data Repository: Human African Trypanosomiasis, Number of new reported cases (T.b. gambiense and T.b. rhodesiense) n.d., viewed May 18, 2015,

Global Health Observatory Data Repository: Buruli Ulcer, Number of new reported cases n.d., viewed May 18, 2015,

Global Health Observatory Data Repository: Dracun-culiasis, Number of cases n.d., viewed May 18, 2015,

WIPO Re:Search Guiding Principles n.d., viewed May 18, 2015,

Dent J, Ramamoorthi R, Graef K, et al. 2013, WIPO Re:Search: a consortium catalyzing research and pro-duct development for neglected tropical diseases. Pharmaceutical Patent Analyst, vol.2(5): 591–596. http://dx.doi.org/10.4155/ppa.13.49.

Dickson M and Gagnon J P, 2004, The cost of new drug discovery and development. Discovery Medicine, vol.4(22): 172–179.

Dent J, 2015, 2014 Partnership Hub Report: Catalyzing Partnerships for Global Health, BIO Ventures for Global Health, Seattle.

World Health Organization 2015, Ebola Situation Report - 13 May 2015, viewed May 18, 2015,

International Clinical Trials Registry Platform (ICTRP) Search Portal n.d., viewed April 20, 2015,

Clinical Trials Database n.d., viewed April 20, 2015,


DOI: http://dx.doi.org/10.18063/jmds.v1i1.119
(238 Abstract Views, 133 PDF Downloads)

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Jennifer Dent, Katy M. Graef, Paddy Shivanand

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.